Is lecanemab the Alzheimer’s drug that will finally make a difference?
(By Jon Hamilton for NPR) A drug that offers a small benefit to Alzheimer’s patients is making a big splash
Read More
Part D/Prescription Drugs
Medicare Open Enrollment ends December 7th
Medicare health and drug plans can make changes each year—things like cost, coverage, and what providers and pharmacies are in
Read MorePaxlovid Has Been Free So Far. Next Year, Sticker Shock Awaits.
(By Hannah Recht for Kaiser Health News) Nearly 6 million Americans have taken Paxlovid for free, courtesy of the federal
Read MoreEmployers Use Patient Assistance Programs to Offset Their Own Costs
(By Julie Appleby for Kaiser Health News) Anna Sutton was shocked when she received a letter from her husband’s job-based
Read MoreStudy: Alzheimer’s drug shows modest success slowing declines in memory, thinking
(By Jon Hamilton for NPR) An experimental drug that removes a substance called amyloid from the brain appears to slow
Read MoreHas the demand for $0 premium Medicare Advantage plans peaked?
eHealth, a marketplace for health insurance and Medicare plans, reports in their latest report that the average premiums for Medicare
Read MoreMedicare Plan Finder Likely Won’t Note New $35 Cap on Out-of-Pocket Insulin Costs
(By Susan Jaffe for Kaiser Health News) A big cut in prescription drug prices for some Medicare beneficiaries kicks in
Read MoreManaging Medicare costs
According to financial experts, healthcare costs for a healthy 65-year-old couple will grow to $673,587 over their life expectancy due
Read MoreThe Average Medicare Beneficiary Has a Choice of 43 Medicare Advantage Plans and 24 Part D Stand-Alone Plans for Coverage in 2023
(Source – Kaiser Family Foundation Published: Nov 10, 2022) For 2023, the typical beneficiary has a choice of 43 Medicare
Read MoreNew VA study finds Paxlovid may cut the risk of long COVID
(By Pien Huang for NPR) It’s well-documented that Paxlovid — a 5-day course of antiviral pills from Pfizer — can
Read More